mazindol , a drug with tricyclic structure unrelated to amphetamine and other anorectic drugs , has been used as an anorectic agent in a double blind clinical trial at a dose of 2 mg/day for 12 week ( mazindol v. s. placebo ) , associated with a 1000 calorie diet on 46 obese diabetic patients .
C0024977
mazindol
C0028754
obese